Cardinal Health (NYSE: CAH) today announced that its board of directors has elected J. Michael Losh as an independent director effective December 5. Losh will serve as the chairman of the Audit Committee.
Recent News About Cardinal Health, Inc View More
Oncologists are growing more confident in their ability to meet the requirements of the Medicare Access & CHIP Reauthorization Act (MACRA), according to new research from Cardinal Health Specialty Solutions.
Cordis, a Cardinal Health company (NYSE: CAH), today announced that the U.S. Food and Drug Administration (FDA) has approved its INCRAFT® AAA Stent Graft System for use in complex access anatomies.